Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Kidney cancer, Renal cell cancer, Secondary cancers
Closed
Phase 2
A trial of belzutifan for kidney cancer that has grown into the nearby tissue or spread to another part of the body. It is for people who have a type of kidney cancer called renal cell cancer.
Recruitment start: 4 June 2021
Recruitment end: 31 December 2021
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Mark Tuthill
Merck Sharp & Dohme Ltd
Last reviewed: 20 January 2022
CRUK internal database number: 17741
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
